412 related articles for article (PubMed ID: 27613163)
1. Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver.
Tian Y; Ma J; Wang W; Zhang L; Xu J; Wang K; Li D
Mol Cell Biochem; 2016 Nov; 422(1-2):75-84. PubMed ID: 27613163
[TBL] [Abstract][Full Text] [Related]
2. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
[TBL] [Abstract][Full Text] [Related]
6. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
[TBL] [Abstract][Full Text] [Related]
7. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.
Zhang Y; Chen ML; Zhou Y; Yi L; Gao YX; Ran L; Chen SH; Zhang T; Zhou X; Zou D; Wu B; Wu Y; Chang H; Zhu JD; Zhang QY; Mi MT
Mol Nutr Food Res; 2015 Aug; 59(8):1443-57. PubMed ID: 25943029
[TBL] [Abstract][Full Text] [Related]
9. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
10. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice.
Tian J; Cai M; Jin S; Chen Q; Xu J; Guo Q; Yan Z; Han X; Lu H
Pharm Biol; 2023 Dec; 61(1):647-656. PubMed ID: 37038833
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injury.
Chen X; Chen C; Fan S; Wu S; Yang F; Fang Z; Fu H; Li Y
J Neuroinflammation; 2018 Apr; 15(1):116. PubMed ID: 29678169
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats.
Ding S; Jiang J; Zhang G; Bu Y; Zhang G; Zhao X
PLoS One; 2017; 12(8):e0183541. PubMed ID: 28817690
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.
Zeng W; Shan W; Gao L; Gao D; Hu Y; Wang G; Zhang N; Li Z; Tian X; Xu W; Peng J; Ma X; Yao J
Sci Rep; 2015 Nov; 5():16013. PubMed ID: 26525891
[TBL] [Abstract][Full Text] [Related]
14. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
15. Feeding restriction alleviates high carbohydrate diet-induced oxidative stress and inflammation of Megalobrama amblycephala by activating the AMPK-SIRT1 pathway.
Xu C; Liu WB; Remø SC; Wang BK; Shi HJ; Zhang L; Liu JD; Li XF
Fish Shellfish Immunol; 2019 Sep; 92():637-648. PubMed ID: 31271836
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin 1 activation alleviates primary biliary cholangitis via the blocking of the NF-κB signaling pathway.
Li Y; Xi Y; Tao G; Xu G; Yang Z; Fu X; Liang Y; Qian J; Cui Y; Jiang T
Int Immunopharmacol; 2020 Jun; 83():106386. PubMed ID: 32193100
[TBL] [Abstract][Full Text] [Related]
17. The role of AMPKα2 in the HFD-induced nonalcoholic steatohepatitis.
Zhang X; Liu S; Zhang C; Zhang S; Yue Y; Zhang Y; Chen L; Yao Z; Niu W
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165854. PubMed ID: 32502647
[TBL] [Abstract][Full Text] [Related]
18. Combination of luteolin and lycopene effectively protect against the "two-hit" in NAFLD through Sirt1/AMPK signal pathway.
Zhu Y; Liu R; Shen Z; Cai G
Life Sci; 2020 Sep; 256():117990. PubMed ID: 32574665
[TBL] [Abstract][Full Text] [Related]
19. A novel combination of metformin and resveratrol alleviates hepatic steatosis by activating autophagy through the cAMP/AMPK/SIRT1 signaling pathway.
Afshari H; Noori S; Zarghi A
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):3135-3148. PubMed ID: 37209153
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease.
Li L; Hai J; Li Z; Zhang Y; Peng H; Li K; Weng X
Food Chem Toxicol; 2014 Jan; 63():166-73. PubMed ID: 23978414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
